Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Apple
AAPL
|
+$975M |
| 2 |
Amazon
AMZN
|
+$708M |
| 3 |
UnitedHealth
UNH
|
+$634M |
| 4 |
Rivian
RIVN
|
+$504M |
| 5 |
TJX Companies
TJX
|
+$483M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.1B |
| 2 |
NVIDIA
NVDA
|
+$814M |
| 3 |
L3Harris
LHX
|
+$714M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$503M |
| 5 |
Texas Instruments
TXN
|
+$468M |
Sector Composition
| 1 | Technology | 32.52% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.42% |
| 4 | Financials | 9.67% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Silgan Holdings
SLGN
$4.71B
| $3.58M | ﹤0.01% |
83,650
+7,649
| +10% | +$328K |
|
1152
NVR
NVR
$23.3B
| $3.57M | ﹤0.01% |
605
+14
| +2% | +$82.7K |
|
|
SC
1153
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $3.57M | ﹤0.01% |
85,003
+252
| +0.3% | +$10.6K |
|
1154
Rogers Communications
RCI
$19.4B
| $3.55M | ﹤0.01% |
74,542
| – | – |
|
1155
Corcept Therapeutics
CORT
$7.6B
| $3.5M | ﹤0.01% |
176,591
+15,249
| +9% | +$302K |
|
1156
AGNC Investment
AGNC
$10.7B
| $3.48M | ﹤0.01% |
231,084
-275,164
| -54% | -$4.14M |
|
1157
Kimco Realty
KIM
$15.2B
| $3.46M | ﹤0.01% |
140,183
+55,423
| +65% | +$1.37M |
|
1158
AES
AES
$9.19B
| $3.45M | ﹤0.01% |
141,835
-12,723
| -8% | -$309K |
|
1159
Vanguard FTSE All-World ex-US ETF
VEU
$49.7B
| $3.44M | ﹤0.01% |
56,195
+425
| +0.8% | +$26K |
|
1160
Tencent Music
TME
$38.5B
| $3.38M | ﹤0.01% |
493,622
-205,803
| -29% | -$1.41M |
|
1161
Insperity
NSP
$2B
| $3.31M | ﹤0.01% |
28,058
+3,240
| +13% | +$383K |
|
1162
Boston Properties
BXP
$12.3B
| $3.28M | ﹤0.01% |
28,497
-146
| -0.5% | -$16.8K |
|
1163
Sutro Biopharma
STRO
$76.8M
| $3.28M | ﹤0.01% |
220,045
+3,232
| +1% | +$48.2K |
|
1164
Celanese
CE
$5.06B
| $3.26M | ﹤0.01% |
19,394
-104,462
| -84% | -$17.6M |
|
1165
Royal Caribbean
RCL
$92.5B
| $3.26M | ﹤0.01% |
42,395
+1,029
| +2% | +$79.1K |
|
1166
Incyte
INCY
$16.3B
| $3.21M | ﹤0.01% |
43,674
+4,770
| +12% | +$350K |
|
|
FBC
1167
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $3.19M | ﹤0.01% |
66,530
+16,856
| +34% | +$808K |
|
1168
RH
RH
$4.08B
| $3.16M | ﹤0.01% |
5,906
+1,709
| +41% | +$916K |
|
|
IMGN
1169
DELISTED
Immunogen Inc
IMGN
| $3.14M | ﹤0.01% |
423,863
+404,198
| +2,055% | +$3M |
|
1170
Quanta Services
PWR
$57.6B
| $3.12M | ﹤0.01% |
27,220
+13,692
| +101% | +$1.57M |
|
1171
Ultragenyx Pharmaceutical
RARE
$2.95B
| $3.09M | ﹤0.01% |
36,688
-61,841
| -63% | -$5.2M |
|
1172
Vanguard Mid-Cap ETF
VO
$88.1B
| $3.04M | ﹤0.01% |
11,926
+4,596
| +63% | +$1.17M |
|
1173
Huntington Ingalls Industries
HII
$10.8B
| $3.04M | ﹤0.01% |
16,261
-136,457
| -89% | -$25.5M |
|
1174
Arch Capital
ACGL
$34.4B
| $3.01M | ﹤0.01% |
67,748
-9,672
| -12% | -$430K |
|
1175
Teladoc Health
TDOC
$1.36B
| $2.99M | ﹤0.01% |
32,577
+2,415
| +8% | +$222K |
|